| payload |
{"created_at":"2026-04-08T21:48:34.772 {"created_at":"2026-04-08T21:48:34.772061+00:00","dedupe_key":"signal_enriched:discovery_ipo_delta:01d573679c9f37bb","evidence_event_ids":["evt_2a641a0a1b5c"],"signal_type":"discovery_ipo_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbzI5ZjVud3VYd01WR0RJcWdwcDRuaEhVZFdxbzExZFZfRmloS2dFTnBqUy12OHVkdjA4dDdoOUJ1Y3hkY2tDdC0zTmlWWmRIalFISXpKLWp0UDk5d0ZVMTB0S1VaeDRTSWpLZmJ4UDNoWkIyVEhjZ19EQm1Pc2laOHBUU3B0NUhmRjhxRzc5SzdRVmZ0TkZDOV9UTDk5eDhGc1U5bTdvSTVHY2thT1lRbVBwNFVmdw?oc=5","as_of":"2026-04-08T21:48:34.772061+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbzI5ZjVud3VYd01WR0RJcWdwcDRuaEhVZFdxbzExZFZfRmloS2dFTnBqUy12OHVkdjA4dDdoOUJ1Y3hkY2tDdC0zTmlWWmRIalFISXpKLWp0UDk5d0ZVMTB0S1VaeDRTSWpLZmJ4UDNoWkIyVEhjZ19EQm1Pc2laOHBUU3B0NUhmRjhxRzc5SzdRVmZ0TkZDOV9UTDk5eDhGc1U5bTdvSTVHY2thT1lRbVBwNFVmdw?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_9f27033867a2abe9","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-10T01:23:49.944666+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbzI5ZjVud3VYd01WR0RJcWdwcDRuaEhVZFdxbzExZFZfRmloS2dFTnBqUy12OHVkdjA4dDdoOUJ1Y3hkY2tDdC0zTmlWWmRIalFISXpKLWp0UDk5d0ZVMTB0S1VaeDRTSWpLZmJ4UDNoWkIyVEhjZ19EQm1Pc2laOHBUU3B0NUhmRjhxRzc5SzdRVmZ0TkZDOV9UTDk5eDhGc1U5bTdvSTVHY2thT1lRbVBwNFVmdw?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"gstatic.com","publisher_resolution":"canonical_aggregator_unresolved","requested_url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQbzI5ZjVud3VYd01WR0RJcWdwcDRuaEhVZFdxbzExZFZfRmloS2dFTnBqUy12OHVkdjA4dDdoOUJ1Y3hkY2tDdC0zTmlWWmRIalFISXpKLWp0UDk5d0ZVMTB0S1VaeDRTSWpLZmJ4UDNoWkIyVEhjZ19EQm1Pc2laOHBUU3B0NUhmRjhxRzc5SzdRVmZ0TkZDOV9UTDk5eDhGc1U5bTdvSTVHY2thT1lRbVBwNFVmdw?oc=5","source_event_id":"evt_2a641a0a1b5c","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"19112c2a9fde4484","kind":"ipo_calendar","published_at":"2026-04-08T20:42:40+00:00","publisher_domain":"gstatic.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.78,"dates_mentioned":[],"entities":[{"asset_class":"equity","name":"Avalyn Pharma","relevance":"primary","symbol":"","type":"company"},{"asset_class":"private_investor","name":"Novo","relevance":"supporting","symbol":"","type":"investor"},{"asset_class":"media","name":"Bloomberg","relevance":"source","symbol":"","type":"publisher"}],"event_type":"listing","information_gaps":["Whether the IPO filing is confidential or public (e.g., S-1 vs. other form) is not stated.","IPO size, expected pricing range, number of shares, and timing are not provided.","Any financial metrics, stage of clinical development, or product pipeline details are not included in the provided text.","No IPO ticker symbol or exchange listing venue is mentioned.","The provided article text appears to contain only page styling/HTML fragments, not the substantive Bloomberg content."],"key_facts":["Signal headline states: \"Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO\" (Bloomberg).","Source summary repeats the same claim: Avalyn Pharma files for a US IPO.","No additional IPO terms (size, ticker, pricing, underwriters) are present in the provided text."],"numeric_claims":[],"primary_claim":"Avalyn Pharma, described as Novo-backed and a respiratory drugmaker, has filed for a US IPO.","relevance_score":0.72,"sentiment":"neutral","source_quality":"high","summary":"Bloomberg reports that Novo-backed respiratory drugmaker Avalyn Pharma has filed for a US IPO.","topics":["IPO filing","biopharma","respiratory drugs","US capital markets","Novo-backed"]},"source":"Bloomberg","source_domain":"gstatic.com","summary":"Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO Bloomberg","tickers":[],"title":"Novo-Backed Respiratory Drugmaker Avalyn Pharma Files for US IPO - Bloomberg","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}}... |